Business leaders, healthcare industry experts and the federal government come together to address the benefits and risks surrounding ChatGPT (generative AI chatbot).
Even with the exciting buzz surrounding ChatGPT, many prominent tech, business, research and academic leaders are calling for a moratorium on the next generation development of generative AI technology until guidelines can be developed and adopted to ensure the responsible and ethical deployment of generative AI models while protecting people’s rights, safety, security. And there are varying opinions on what the role of the federal government should be and how far-reaching.
There is general consensus that, while the use of generative AI by businesses across industries grows exponentially, there is a lack of corporate guidelines and regulation coupled with a number of unknowns regarding cybersecurity, biosecurity, safety, and bias that still have not been adequately addressed.
What might concerns be for the healthcare industry? And how has the White House responded to calls for regulation surrounding generative AI?
Specific to the healthcare industry, generative AI technology brings about concerns related to providers and patients, such as:
📝 Content identified from credible sources - e.g., an established healthcare governing body or professional organization with the proper qualifications and credentials to oversee content guidelines designed for providers, clinical protocols and patient care.
🤖 ChatGPT is trained to be neutral and polite (mostly) and therefore lacks empathy. It does not write content expressing empathy and emotion that engages and humanizes the patient experience.
🩺 ChatGPT may not disseminate clinical information in an understandable fashion (using layperson’s language versus clinical terms) or even spread disinformation with the risk that people will rely on these systems for medical and behavioral health advice.
Recently, the White House announced new actions that will seek responsible innovation in generative AI while protecting people’s rights, safety, security, and the economy. The actions comprise a Blueprint for an AI Bill of Rights, as well as an AI Risk Management Framework and a roadmap for creating a National AI Research Resource. The new initiatives will be supported by:
✅New investments to drive responsible AI research and development in areas that include climate, agriculture, energy, public health, education, and cybersecurity.
✅Public assessments of existing generative AI systems consistent with responsible disclosure principles and the Blueprint for an AI Bill of Rights.
✅Policies to ensure the U.S. government is taking the lead on mitigating AI risks (such as bias) and identifying AI opportunities across industries.
These initiatives certainly represent important steps in creating guardrails around this powerful, game-changing, yet high-risk technology, in order for the U.S. to seize the vast opportunities it presents, while mitigating risks.
So far, reaction to the White House initiatives has been mixed Some advocates for government controls believe it does not go far enough, wanting more checks and balances, while some tech leaders fear that regulation could stifle AI innovation.
In the end, business leaders and government officials will need to continue their dialog to drive responsible, trustworthy, and ethical innovation with proper safeguards that mitigate risks while still fueling an environment of innovation and technology breakthroughs.
Do you think further advancements in generative GPT should be put on hold until there is more consensus and guidelines in place to mitigate the potential risks in using the chatbot technology? 📝
Follow Equilibrium Point for more trending topics on AI/ML.
Learn more ➡ https://www.nytimes.com/2023/03/29/technology/ai-artificial-intelligence-musk-risks.html